The story of Viagra and its effect on the healthcare industry presents a nuanced scenario for investors . While the initial blockbuster status of the drug's flagship product generated substantial returns , https://declanychg465673.atualblog.com/47637336/the-little-blue-pill-and-drug-companies-a-potentially-problematic-venture